Akhtar S, Sheikh AA and Qureshi HU. Chewing areca nut, betel quid, oral snuff, cigarette smoking and the risk of oesophageal squamous-cell carcinoma in South Asians: a multicentre case-control study. European journal of cancer (Oxford, England : 1990) 2012;48:655-61
Arora S, Aggarwal P, Pathak A, Bhandari R, Duffoo F and Gulati SC. Molecular genetics of head and neck cancer (Review). Molecular medicine reports 2012;6:19-22
Cadoni G, Boccia S, Petrelli L, Di Giannantonio P, Arzani D, Giorgio A, De Feo E, Pandolfini M, Gallì P, Paludetti G and Ricciardi G. A review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolism. Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 2012;32:1-11
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer 2015;136:E359-86
Ghapanchi J, Ranjbar Z and Mokhtari MJ. The LncRNA H19 rs217727 Polymorphism Is Associated with Oral Squamous Cell Carcinoma Susceptibility in Iranian Population. 2020;2020:1634252
Huang W, Song J, Jia XW, Chen YX, Shi J and Jiang X. Interleukin-10 rs1800896 polymorphism is associated with increased head and neck cancer risk but not associated with its clinical stages. Oncotarget 2017;8:37217-37224
Ji Y, Feng G, Hou Y, Yu Y, Wang R and Yuan H. Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin. Cancer medicine 2020;9:3954-3963
Jiang Y, Wu K, Cao W, Xu Q, Wang X, Qin X, Wang X, Li Y, Zhang J and Chen W. KTN1-AS1Long noncoding RNA promotes head and neck squamous cell carcinoma cell epithelial-mesenchymal transition by targeting. Epigenomics 2020;12:487-505
Lacko M, Roelofs HM, Te Morsche RH, Voogd AC, Ophuis MB, Peters WH and Manni JJ. Genetic polymorphism in the conjugating enzyme UGT1A1 and the risk of head and neck cancer. International journal of cancer 2010;127:2815-21
Langer CJ. Exploring biomarkers in head and neck cancer. Cancer 2012;118:3882-92
Leemans C, Braakhuis B and Brakenhoff R. The molecular biology of head and neck cancer. Nature reviews Cancer 2011;11:9-22
Li L and Zhang X. Genetic Polymorphisms in the RAD51 Gene with a Risk of Head and Neck Cancer and Esophageal Cancer: A Meta-Analysis. 2019;2019:2789035
Li L and Zhang ZT. Genetic Association between NFKBIA and NFKB1 Gene Polymorphisms and the Susceptibility to Head and Neck Cancer: A Meta-Analysis. 2019;2019:6523837
Marín-Béjar O, Mas A, González J, Martinez D, Athie A, Morales X, Galduroz M, Raimondi I, Grossi E, Guo S, Rouzaut A, Ulitsky I and Huarte M. The human lncRNA LINC-PINT inhibits tumor cell invasion through a highly conserved sequence element. Genome biology 2017;18:202
Negri E, Boffetta P, Berthiller J, Castellsague X, Curado MP, Dal Maso L, Daudt AW, Fabianova E, Fernandez L, Wünsch-Filho V, Franceschi S, Hayes RB, Herrero R, Koifman S, Lazarus P, Lence JJ, Levi F, Mates D, Matos E, Menezes A, Muscat J, Eluf-Neto J, Olshan AF, Rudnai P, Shangina O, Sturgis EM, Szeszenia-Dabrowska N, Talamini R, Wei Q, Winn DM, Zaridze D, Lissowska J, Zhang ZF, Ferro G, Brennan P, La Vecchia C and Hashibe M. Family history of cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. International journal of cancer 2009;124:394-401
Sabir M, Baig RM, Mahjabeen I and Kayani MA. Novel germline CDK4 mutations in patients with head and neck cancer. Hereditary cancer in clinical practice 2012;10:11
Siegel R, Ward E, Brawley O and Jemal A. Cancer statistics, 2011. Ca Cancer J Clin 2011;61
Smith EM, Rubenstein LM, Haugen TH, Pawlita M and Turek LP. Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. Journal of oncology 2012;2012:571862
Sturgis EM and Wei Q. Genetic susceptibility--molecular epidemiology of head and neck cancer. Current opinion in oncology 2002;14:310-7
Wu B, Liu J, Wang B, Liao X, Cui Z and Ding N. Association on polymorphisms in LncRNA HOTAIR and susceptibility to HNSCC in Chinese population. Eur Rev Med Pharmacol Sci 2018;22:702-706
Xin C, Li JL, Zhang YX and Yu ZH. Polymorphisms in lncRNA PTENP1 and the risk of oral squamous cell carcinoma in a Chinese population. Eur Rev Med Pharmacol Sci 2018;22:5583-5587
Yoshizaki T, Ito M, Murono S, Wakisaka N, Kondo S and Endo K. Current understanding and management of nasopharyngeal carcinoma. Auris, nasus, larynx 2012;39:137-44
Yuan Z, Xiu C, Liu D, Zhou G, Yang H, Pei R, Ding C, Cui X, Sun J and Song K. Long noncoding RNA LINC-PINT regulates laryngeal carcinoma cell stemness and chemoresistance through miR-425-5p/PTCH1/SHH axis. Journal of cellular physiology 2019;234:23111-23122
Zhang C, Yin D, Sun S and Han L. The use of lncRNA analysis for stratification management of prognostic risk in patients with NSCLC. European review for medical and pharmacological sciences 2017;21:115-119